Pan, Carolyn K <br/><br/>
Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.  [electronic resource] 

 -  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics  Jun 2011 
 - 219-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-7732 
<br/><br/><label>Standard No.: </label>10.1089/jop.2010.0158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Bruch Membrane--radiation effects<br/>Choroid--drug effects<br/>Choroidal Neovascularization--drug therapy<br/>Delayed-Action Preparations--administration & dosage<br/>Disease Models, Animal<br/>Drug Compounding<br/>Fluorescein Angiography--drug effects<br/>Intravitreal Injections<br/>Lactic Acid--chemistry<br/>Laser Coagulation--adverse effects<br/>Male<br/>Polyethylene Glycols--chemistry<br/>Polyglycolic Acid--chemistry<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Rats<br/>Rats, Inbred BN<br/>Severity of Illness Index<br/>Time Factors<br/>Vascular Endothelial Growth Factors--antagonists & inhibitors